Fampridine
Key facts
Active substance |
Fampridine
|
Therapeutic area |
Neurology
|
Decision number |
P/213/2010
|
PIP number |
Fampridine
|
Pharmaceutical form(s) |
Prolonged-release tablet
|
Condition(s) / indication(s) |
Multiple sclerosis with walking disability
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Acorda Therapeutics, Inc.
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|